Management of Metastatic Breast Cancer

Metastatic Disease: Interview with Kathy D Miller, MD

NEW ISSUE

Dr Miller is Sheila D Ward Scholar of Medicine and Associate Professor of Medicine in the Department of Hematology/Oncology at the Indiana University School of Medicine in Indianapolis, Indiana.

Metastatic Disease: Interview with Hope S Rugo, MD

NEW ISSUE

Dr Rugo is Clinical Professor of Medicine at Carol Franc Buck Breast Care Center and Co-director of the Breast Oncology Clinical Trials Program at the University of California, San Francisco Comprehensive Cancer Center in San Francisco, California.

Metastatic Disease: Interview with Nicholas J Robert, MD

NEW ISSUE

Dr Robert is Chairman of the Research Committee in the Inova Fairfax Hospital Cancer Center and Chair of the Breast Cancer Committee at the US Oncology Research Network in Fairfax, Virginia.

Metastatic Disease: Interview with Joanne L Blum, MD, PhD

NEW ISSUE

Dr Blum is Director of the Hereditary Cancer Risk Program and Research Site Leader at Baylor-Charles A Sammons Cancer Center in Dallas, Texas.

Interview with George W Sledge Jr, MD

Dr Sledge is Ballve-Lantero Professor of Oncology and Professor of Medicine and Pathology at Indiana University School of Medicine in Indianapolis, Indiana.

Interview with William J Gradishar, MD

Dr Gradishar is Professor of Medicine and Director of Breast Medical Oncology at Northwestern University Feinberg School of Medicine's Robert H Lurie Comprehensive Cancer Center in Chicago, Illinois.

Interview with Harold J Burstein, MD, PhD

Dr Burstein is Assistant Professor of Medicine at Dana-Farber Cancer Institute's Breast Oncology Center at Harvard Medical School in Boston, Massachusetts.

This pilot website educational tool was developed to supplement, and in no way replace, any information patients have received from a physician, nurse or other oncology professional. This site contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Oncology professionals should refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Patients should refer to their oncologist as their primary source of information. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.